TEMOZOLOMIDE 250 mg Pill - gray & white capsule/oblong, 22mm

Pill with imprint TEMOZOLOMIDE 250 mg is Gray & White, Capsule/Oblong and has been identified as Temozolomide 250 mg. It is supplied by Mayne Pharma US.

Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEMOZOLOMIDE 250 mg

Temozolomide

Imprint: TEMOZOLOMIDE 250 mg
Strength: 250 mg
Color: Gray & White
Size: 22.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Alkylating agents
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: Mayne Pharma US
Manufacturer: IDT Australia Limited
National Drug Code (NDC): 51862-0088 (Discontinued)
Inactive Ingredients: lactose anhydrous, sodium starch glycolate type A potato, silicon dioxide, stearic acid, tartaric acid, gelatin, methylparaben sodium, propylparaben sodium, sodium lauryl sulfate, ferrosoferric oxide, titanium dioxide, water
Note: Inactive ingredients may vary.